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Changes in cerebral blood flow (CBF) during a hyperglycemic challenge were mapped,
using perfusion-weighted MRI, in a group of non-human primates. Seven female
baboons were fasted for 16 h prior to 1-h imaging experiment, performed under general
anesthesia, that consisted of a 20-min baseline, followed by a bolus infusion of glucose
(500 mg/kg). CBF maps were collected every 7 s and blood glucose and insulin levels
were sampled at regular intervals. Blood glucose levels rose from 51.3± 10.9 to 203.9±
38.9 mg/dL and declined to 133.4± 22.0 mg/dL, at the end of the experiment. Regional
CBF changes consisted of four clusters: cerebral cortex, thalamus, hypothalamus, and
mesencephalon. Increases in the hypothalamic blood flow occurred concurrently with
the regulatory response to systemic glucose change, whereas CBF declined for other
clusters. The return to baseline of hypothalamic blood flow was observed while CBF
was still increasing in other brain regions. The spatial pattern of extra-hypothalamic CBF
changes was correlated with the patterns of several cerebral networks including the
default mode network. These findings suggest that hypothalamic blood flow response to
systemic glucose levels can potentially be explained by regulatory activity. The response
of extra-hypothalamic clusters followed a different time course and its spatial pattern
resembled that of the default-mode network.
Keywords: hyperglycemic challenge, cerebral blood flow, perfusion imaging, resting state network, default state
network, arterial spin labeling
INTRODUCTION
Recent evidence suggest that a dysregulation in the central nervous system (CNS)’s control
over energy intake, storage, and expenditure contributes to the development of many common
metabolic disorders including type 2 diabetes mellitus, insulin resistance, and hyperlipidemia
(Jordan et al., 2010). The exact mechanism of CNS dysregulation in the development of these
Kochunov et al. Cerebral Blood Flow during Hyperglycemic Challenge
diseases is still unknown. The CNS processes information about
the body’s nutritional state and acts as the main regulatory
center to ensure the maintenance of energy homeostasis (Jordan
et al., 2010). There is an urgent requirement for biologically
relevant models to explain the role of cerebral dysregulation
in metabolic disorders; non-human primate (NHP) models
have potential for this purpose. NHP models are essential
translational models for the study of dysmetabolic conditions
and the role of the CNS therein (Cabrera et al., 2006; Pound
et al., 2014). It is recognized that small animal models are
limited for advancing our understanding of the important neuro-
regulatory mechanisms that are key drivers of metabolic health
in humans (Burcelin, 2010). For example, the contribution of
brain insulin signaling to hepatic glucose production in mice and
rats differs markedly from its contribution in larger animals and
consequently, rodent models offer only very limited translational
value for studying hepatic glucose production: a key driver of
elevated plasma glucose in type 2 diabetes (Burcelin, 2010).
Hence, NHPs provide critical intermediary models, both for
bridging rodent findings to the likelihood of clinical relevance
and for identifying novel mechanisms operational only in the
higher species. A large body-size NHP, such as the baboon, that
enables highly controlled and detailed study at the whole body
systems level is critical for advancing our understanding of the
CNS’s role in metabolic health and disease (Higgins et al., 2016).
While the baboon is an established general preclinical model
for obesity, cardiovascular disease, and type 2 diabetes (Chavez
et al., 2008; Guardado-Mendoza et al., 2009); techniques and
methodologies that enable the incorporation of trenchant CNS
assessments into studies using this model are currently limited.
Advanced brain imaging approaches that are deployable during
whole body metabolic studies in this model are particularly
lacking.
The rationale of this study, thus, is to aid the development
of NHP model of cerebral regulation of metabolic function by
combining advanced functional neuroimaging technique with
a commonly used metabolic challenge to replicate previous
findings in humans. Neuroimaging studies in humans have
demonstrated that brain’s response to hyperglycemic challenge
can serve as a potential biomarker of the severity of cerebral
dysregulation observed in diverse metabolic disorders such as
obesity, type 2 diabetes mellitus, and hypoglycemic unawareness
(Matsuda et al., 1999; Choi et al., 2003; Criego et al., 2005).
Specifically, an inhibited and/or time-delayed brain’s response to
infusion of nutrients under a fasting glycemia was observed in
patients withmetabolic disorder and reversal of this response was
suggested to be a potential treatment target for pharmacological
treatments (Matsuda et al., 1999). We compared the trends
observed in baboons, under general anesthesia, to the results
of similar studies in humans to help the development of
NHP models of dysregulation of cerebral control in metabolic
disorders.
Many earlier fMRI studies of CNS responses to hyperglycemic
challenge were methodologically limited to a single slice image
to achieve the necessary temporal resolution (Matsuda et al.,
1999; Liu et al., 2000). The follow up whole-brain PET
studies have helped to clarify the physiologic meaning of
these findings by demonstrating significant changes in the
hypothalamic and extra-hypothalamic cerebral blood flow (CBF)
following the glucose infusion (Cranston et al., 2001; Teh
et al., 2010). The magnitude and timing of the hypothalamic
CBF changes were shown to be correlated with subject’s
body mass index and fasting levels of glucose and insulin
(Matsuda et al., 1999; Liu et al., 2000). The physiological
meaning of the extra-hypothalamic CBF changes was more
difficult to interpret with many studies leaving it unexplained
(Cranston et al., 2001; Teh et al., 2010). Recent improvements
in the MRI technology have enabled for time-resolved, non-
invasive measurements of CBF throughout the brain using
arterial spin labeling (ASL; Detre and Alsop, 1999). A study
by Page and colleagues used ASL-fMRI to show that even
minor (<10 mg/dL) alterations in glycemia lead to increases
in the hypothalamic CBF (Page et al., 2009). This study also
observed significant CBF changes in the extra-hypothalamic
regions but the gap of 30 min between measurements prevented
them from reporting on the temporal relationship between the
hypothalamic and extra-hypothalamic CBF changes (Page et al.,
2009).
Our pilot study was designed to better characterize
hypothalamic and extra-hypothalamic CBF trends during
a hyperglycemic challenge. Toward this goal, we combined
the ASL-fMRI with peripheral sampling of glucose, insulin
and C-peptide to map the transition from fasting glycemia
to hyperglycemia. Our aims were to study the hypothalamic
involvement in metabolic regulation and to attempt to explain
CBF changes in the extra-hypothalamic regions. We performed
this study in a large NHP, the baboon (Papio hamadryas
Sp.). We are developing the baboon as a preclinical animal
model to study the physiology and genetics of common
human metabolic disorders including insulin resistance,
diabetes, obesity, and dyslipidemia (Guardado-Mendoza
et al., 2009). Recently, we successfully and safely induced
diabetes in conscious baboons through a single dose of
pharmaceutical-grade steptozotocin (Chen et al., 2014; Frost
et al., 2015). A comprehensive characterization of hypothalamic
and extra-hypothalamic CBF will help us better understand
metabolic regulation in both forms of diabetic (I and II)
conditions. From a neuroimaging perspective, baboons
offer the advantage of having among the largest brains of
commonly studied laboratory primate (Kochunov et al., 2009).
Furthermore, our previous neuroimaging studies in baboons
have demonstrated that the baboon model offers clinically
relevant structural, functional, physiological, and metabolic
information about brain structure, function, development,
and genetic variability (Kochunov et al., 2009; Wey et al.,
2010).
MATERIALS AND METHODS
Animal Subjects and Experimental
Protocol
Seven adult (mean age = 9.17 ± 1.2 years [range: 8.4–11.7
years]) female baboons (P. hamadryas Sp.) were selected from
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a large, breeding colony maintained by the Southwest National
Primate Research Center (SNPRC). To reduce potential gender-
related differences in regional glucose metabolism, we selected
female animals in this study. The average body weight was 17.9
± 3.5 kg (range 15.4–25.4 kg). All animals had a stable weight
pattern (<3% change over the last 12 month) with normal
euglycemic blood glucose values ([Glc] = 89 ± 9 mg/dL) on
entry to the study. Animal handling and anesthesia protocols
were optimized for fMRI and are described elsewhere (Kochunov
et al., 2009). Animals were fasted for 16 h, with full access to
water, before being transported from the SNPRC to the animal
preparation area at the Research Imaging Institute (RII) at
the University of Texas Health Science Center at San Antonio
(UTHSCSA). Each animal was sedated with an intramuscular
injection of s-ketamine 10 mg/kg (KetaVed., Phoenix Scientific,
St. Joseph, Missouri), intubated with an MR-compatible tracheal
tube and 18 gauge catheters were inserted into the left and right
saphenous veins. Animals were then moved to the MRI room
where anesthesia was induced and maintained by mechanical
ventilation, at the rate of 10 respiration/minute, with 2%
Isoflurane, Animal’s heart rate, end-tidal CO2 concentrations and
core body temperature were monitored using MRI compatible
equipment from 15 min prior to imaging and throughout
the imaging experiment. Each 60 min long fMRI session
consisted of 20 min of baseline imaging followed by a bolus
injection of glucose (dextrose, 50%) calculated at 500 mg/kg
of body weight into the left saphenous vein. All animal
protocols were reviewed and approved by the Institutional
Animal Care and Use Committee of Texas Biomedical Research
Institute.
Peripheral Measurements
Blood was drawn from the right saphenous vein at 5 min
intervals for glucose measurements in all animals. In addition,
5 ml blood draws were performed at 0, 10, 20, 22.5, 27.5,
35, 45, and 55 min to ascertain insulin and C-peptide plasma
concentrations in five of the seven animals. Whole blood
glucose was measured with a glucometer (Accu-chek AVIVA,
Roche Diagnostics). We confirmed its accuracy ([Glc]plasma =
1.12×[Glc]blood + 4.1; r2 = 0.99; p < 10-4) by analyzing 10
random glucose measurements, in the first two animals, using
the Alfa Wasserman ACE clinical chemistry instrument (West
Caldwell., NJ). Plasma insulin and C-peptide were measured by
immunoassay using the Immulite Analyzer (Diagnostic Products
Corporation, Los Angeles, CA).
Imaging
Measurement of cerebral perfusion was performed using a
pseudo-continuous ASL EPI sequence with the following
parameters: TR/TE = 3,500/16 ms, labeling duration = 2.1 s,
post-labeled delay of 700 ms, 15 contiguous slices with 3 mm
slice thickness, matrix = 64 by 64, FOV = 12.8 × 12.8 cm (2
× 2 × 3 mm resolution), labeling gradient of 0.6 G/cm with
details presented elsewhere (Wey et al., 2010). Alternating labeled
and non-labeled images were acquired in pairs. Co-registered.,
high-resolution, 3D structural images were collected using an
optimized structural protocol described elsewhere (Kochunov
and Duff Davis, 2009).
At the end of the study, the mean transit time (MTT) between
the site of injection and cerebrum was measured using a bolus
of an exogenous agent (gadodiamide). A human adult dose
(0.2 ml/kg) of gadodiamide (OMNISCAN, GE Healthcare, USA)
was administered to left saphenous vein. A susceptibility (T2∗)
sensitive EPI sequence with TR = 1 s was used to image the first
pass of the contrast agent through the cerebral circulation. In
the concentration used for the bolus, gadodiamide is capable of
significantly (∼5- to 10-fold) shortening the relaxation times of
blood with blood’s signal intensity reduced in linear proportion
to the concentration of the contrast agent.
Image Preprocessing
Images were pre-processed using the FMRIB software library
(www.fmrib.ox.ac.uk/fsl/). The pre-processing steps included:
correction for head motion artifacts, removal of non-brain
tissue and calculation of perfusion weighted images using a two
compartmentmodel as described elsewhere (Wey et al., 2010). All
images were spatially registered to a population-average baboon
brain atlas as described in a prior manuscript (Kochunov and
Duff Davis, 2009).
Analysis of CBF Trends
A data-driven analysis approach was used to identify brain
regions, whose CBF were affected by glucose infusion. This
approach, developed to study the effects of pharmacological
agents on brain function (Salmeron and Stein, 2002), uses
the agent’s pharmacokinetic time-activity curve as a parametric
statistical predictor of cerebral activity. The agent’s time-
activity curve is assessed by peripheral measurements of its
concentration. We use a statistical cross-correlation analysis
to identify brain regions where voxel-wise CBF time-activity
curve was significantly correlated with temporal profile of the
peripheral CBF measurements. The cross-correlation analysis
accommodates for potential timing delay between peripheral and
cerebral circulation as well as for the inter subject differences in
the timing of cerebral activity. We chose the blood glucose level
as the predictor variable because glucose level measurements
require collection of only small amounts of blood (<0.1ml
compared to 5ml for measurements of regulatory hormones)
and therefore was performed more frequently (every 5 min)
for improved temporal sampling frequency. The voxel-wise,
cross-correlation analysis was performed using the FSL-FEAT
general linear model tool (Smith et al., 2004). The blood glucose
temporal trends were treated as the contrast. According to the
guidelines given in the FSL-FEAT manual, the CBF and glucose
concentration data were normalized by converting to z-scores.
This was accomplished by subtracting the average baseline values
and dividing the result by the baseline’s standard deviation.
Cross-correlation identified the maximum Pearson correlations
between blood glucose trends and the voxel-wise perfusion
and for the individual animals (Figure 1). The result of this
analysis was the statistical parametric map (SPM) of the voxel-
wise statistical significance, expressed as t-statistics. This map
was thresholded using the Gaussian random field theory at the
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FIGURE 1 | Data analysis was performed in two steps. During the first step (A), cerebral area with CBF trends that followed the trends of blood glucose levels
([Glc]) were identified using cross-correlation analysis. During the second step (B), time-shift analysis was performed to calculate the average, across all significant
voxels, wave-form and the time of onset for individual animals. Cross-correlation is used to calculate the time (ts) which maximizes the correlation-coefficient between
the CBF trends among the individual animals. Correction for individual differences in times provided for a clarified average CBF trend when compared to a simple
averaging (C,D).
significance level of t = 3.0 and cluster-wise significance of p =
0.01 (Figure 1A).
Comparison with the Spatial Pattern of
Resting State Cerebral Networks
We interpreted the regional changes in CBF trend following
glucose uptake by performing a similarity analysis between the
spatial patterns of the glucose-related CBF changes and those
of 20 resting state networks measured in seven unrelated, adult
female baboons (Wey et al., 2011). The animal handling protocol,
maintenance of the anesthesia and mechanical ventilation
frequency (10 respirations/min) were the same with an exception
that vecuronium bromide (0.1 mg/kg) was used to facilitate
endotracheal intubation (Wey et al., 2011). Resting-state fMRI
data were collected with high resolution (1 × 1 × 1.9 mm)
gradient echo EPI sequence (TR/TE = 3000/30 ms). The spatial
patterns of resting state networks were calculated using the
FMRIB Software Library (FSL) MELODIC using default settings.
This analysis produced 20 temporal-concatenated, independent
component (Smith et al., 2004). Pre-processing steps included:
motion correction, brain extraction, temporal band-pass filtering
(0.01–0.08 Hz), and spatial smoothing (Gaussian kernel, FWHM
= 5mm). All images were registered to a high-resolution baboon
brain template and concatenated in time (Kochunov et al., 2009).
The 20 components represented the main modes of coactivation
across all images. These components included the executive
networks, the visual networks, the default mode network, and
the sensory-motor network that were identified through visual
inspection and confirmed with spatial correlation analysis with
the human data (Kelly et al., 2010).
We calculated spatial correlation coefficients between the
SPM of the association between temporal glucose and CBF
trends using FSL’s spatial correlation utility (fslcc) and estimated
significance using a two tailed, one-sample t-test (Kelly et al.,
2010). The level of statistical significance was set at p ≤ 0.001 to
reduce the probability of Type 1 errors associated with multiple
(N = 20) comparisons.
Analysis of Temporal Differences among
Regional CBF Trends
Next, we analyzed the temporal differences among the regional
CBF trends. At the design of the experiment, we expected that
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individual animals may show temporal differences due to both
methodological such as the timing of injection of the bolus
contrast and physiological factors such as individual metabolic
responses to glucose bolus. First, a cross-correlation analysis
was used to correct for intersubject differences in the whole-
brain CBF trends. This correction was necessary as demonstrated
by Figure 1B. The average CBF curve can be distorted by the
individual timing differences if simple averaging is used. The
average CBF curve can be restored by shifting individual curves.
This analysis was performed by calculating the average CBF trend
for all significant voxels. Cross-correlations were then calculated
for the average CBF time trend for each animals and the rest
of the group. This analysis estimated the shift in time (ts) that
maximizes the overlap in the average CBF trends among animals
(Figure 1B) and calculated the average temporal CBF curve by
correcting for individual temporal differences (Figures 1C,D).
Following this correction, we analyzed the temporal
relationship among the CBF trends for four region whose CBF
trends showed a significant association with blood glucose
levels: cortex, thalamus, hypothalamus, and mesencephalon.
These regions were manually segmented by overlaying the
average SPM on the model of population-average cortical
surface model derived from anatomical data of about 200
baboons (Kochunov and Duff Davis, 2009). The potential
co-linearity of the time trends among regions was removed using
a data reduction technique—factor analysis. This analysis was
performed for the 25 min long window of data that started 5
min prior to glucose infusion. Factor analysis used the principal
components analysis (PCA) to obtain linear composites of
time trends for different regions of interest with varimax
rotation used to orthogonalize the eigenvectors. Results of
factor analysis yielded factor loadings (correlations between a
time-trends and a factor) and a standardized Z-score for each
factor.
All images were registered to a high-resolution baboon brain
template and concatenated in time (Kochunov and Duff Davis,
2009).
RESULTS
The state of fasting glycemia was confirmed by measuring stable
baseline blood glucose and plasma levels of insulin and C-
peptide (51.3 ± 10.9mg/dL; 2.6 ± 1.4 µU/ml, and 0.18 ±
0.06 ng/ml, respectively; Figure 2). Infusion of glucose produced
short (∼20min) lasting hyperglycemia (peak value = 203.9
± 38.9mg/dL) and elevations in insulin and C-peptide levels
(Figure 2). During the last 20min, the blood glucose levels and
plasma levels of insulin and C-peptide returned to normal post-
meal values (134.4 ± 22.0mg/dL, 30.6 ± 3.2 µU/ml, and 0.88
± 0.20 ng/ml, respectively). The whole-brain (WB)-CBF values
increased from the average baseline value of 72.4 ± 2.8–76.3
± 3.2mg×100 gm−1×min−1 (observed at 4.2min after glucose
infusion) and remained elevated for ∼15min (average CBF =
75.1 ± 2.5mg×100 gm−1×min−1; Figure 2). About 35% of the
brain voxels showed a statistically-significant (t > 3.0; p < 0.01)
correlation with the glucose concentration trend. The average
CBF trend from these regions was corrected for the individual
differences in the times of onset by time-shifting the CBF
trends. This step clarified the average wave-shape of the whole-
brain CBF. The average CBF trend for these regions showed
a dip-rise-overshoot trend, with the dip (CBF = 65.7mg×100
gm−1×min−1) occurring at 2.2min and preceding the peak CBF
values (CBF = 79.3mg×100 gm−1×min−1), by about 3min
(Figure 2). During the remaining 20min the glucose, insulin
and C-peptide levels returned to typical post-meal values and
the WB-CBF returned to its base-line value (73.2 ± 2.9mg×100
gm−1×min−1).
Regional pattern of statistically significant CBF change
consisted of four regions: cortex, hypothalamus, thalamus, and
mesencephalon (Figure 3). The spatial cross-correlation analysis
between this pattern (Figure 4A) and the spatial patterns of
20 resting-state networks was performed to study its overlap
with regionally specific patterns of activity during resting
state (Figures 4B–D). The highest spatial correlation (r =
0.51, p = 10−6) was observed for the default mode network
(Figure 4B) with both images showing similar spatial patterns
that included superior partial lobe and the pre-frontal and
cingulate areas. Significant spatial correlation were also observed
for the motor-and-sensory (Figure 4C) networks (r = 0.29 and
0.25; respectively, p= 0.0001).
Next, the regions of statistically significant CBF change were
manually delineated for each animal (Figure 5). The CBF trends
for each of these regions of interest were calculated and factor
analysis was used to distilled their temporal trends into two
orthogonal components (Factor 1 and 2), which explained 61
and 24% of the temporal variability, respectively (Figure 6).
Factor 1 loaded on the CBF trends from the thalamus, cortex,
and mesencephalon. Factor 2 loaded on the CBF trends from
hypothalamus. The two factors, were significantly and negatively
correlated (r2 =−0.72; p < 0.001) during the first 4 min after the
glucose infusion and were significantly and positively correlated
(r2 = 0.80; p < 0.001) thereafter (Figure 6). Finally, the MTT,
time between the bolus infusion of the contrast agent and when
its cerebral concentration reached maximum, was calculated to
be 7.8± 2.1 s.
DISCUSSION
We combined perfusion fMRI, time-resolved sampling of
glucose, insulin and C-peptide concentrations and a data-driven
analysis techniques to study the pattern of CBF change during
the transition from fasting glycemia to hyperglycemia. We
performed this study as a part of developing a NHP model
to study the physiology and genetics of human metabolic
disorders. Old-world NHP, such as baboons, are likely to
provide relevant scientific models because they naturally develop
many metabolic diseases observed in humans and therefore
offer clinically relevant responses to therapeutic interventions.
We aimed to study the temporal relationship among the
regional CBF trends and the regulatory response to a large
change in systemic glucose concentrations and compare the
results in baboons to these reported by neuroimaging studies
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FIGURE 2 | (A) Blood glucose concentrations were measured every 5min and then interpolated between time points and averaged for all animals. (B) The plasma
Insulin* (middle) and (C) C-peptide* concentrations were measured at 0, 10, 20, 22.5, 27.5, 35, 45, and 55min and then interpolated between time points and
averaged for all animals. The whole-brain average CBF curve (D) and the average CBF calculated for significant voxels after correction for timing differences (E).
*These data were available for 5 out of 7 animals.
in humans. Our study was designed to better characterize
temporal hypothalamic and extra-hypothalamic CBF trends
during a hyperglycemic challenge. The hyperglycemic challenge,
with the fasting glycemia baseline, was chosen because it
produced robust hypothalamic and extra-hypothalamic CBF
changes in previous imaging studies (Matsuda et al., 1999;
Liu et al., 2000). Many previous neuroimaging studies have
focused on the hypothalamus, leaving the extra-hypothalamic
activations unexplained (Liu et al., 2000; Page et al., 2009).
We used a data-driven analysis technique (Salmeron and Stein,
2002) that did not limit our attention to any specific brain
region. We identified four brain regions: cortex, thalamus,
hypothalamus, and mesencephalon where the temporal CBF
trends were significantly correlated with the temporal trend of
the blood glucose levels. Factor analysis distilled the temporal
trends for these regions into two components: Factors 1 and
2. These two components were orthogonal and contrasted the
CBF trends between extra-hypothalamic (cortex, thalamus, and
mesencephalon) regions (Factor 1) and the hypothalamus (Factor
2). We studied the temporal relationship among them and
the time-trends of peripheral concentrations of insulin and C-
peptide.
Our first aim was to replicate previous findings of
hypothalamic involvement in regulation of systemic glycemia.
The brain’s nutrient and insulin sensing circuits converge in
the hypothalamus, which regulates the systemic response to the
changes in systemic glycemia levels (Lam, 2010). In agreement
with prior findings, the hypothalamic CBF (factor 2) rose within
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FIGURE 3 | The whole-brain average CBF curve and the average CBF calculated for significant voxels after correction for timing differences. The
average statistical parametric map of CBF changes due to glucose infusion was rendered on a 3-D cerebral surface.
FIGURE 4 | The average statistical parametric map of CBF changes (A) Pearson cross-correlation coefficients between glucose infusion and CBF time trends.
The pattern (A) was significantly correlated with the pattern of default-mode (B), motor-and-sensory (C), and the executive control (D) networks (r = 0.51, r = 0.29,
and 0.25, respectively; p ≤ 0.0001).
30 s following the glucose infusion and this timing was consistent
with theMTT (∼8 s) and the delay in the hemodynamic response
(∼15 s). Factor 2 remained elevated for ∼4 min during which
the insulin and C-peptide levels peaked and this was consistent
with the typical timing of insulin release (Cook, 1983). The
release of insulin is triggered by two pathways, peripherally,
via the pancreatic auto-regulation, and cephalically, via the
hypothalamo-pancreatic axis (Chieri et al., 1975; Moltz et al.,
1975). Direct administration of glucose to the hypothalamus was
shown to trigger the release of insulin (Chieri et al., 1975) and
the counter-responses are activated by the direct administration
of insulin (Marty et al., 2007). We consider the occurrence of the
elevated hypothalamic CBF and release of insulin as a suggestive
evidence for activation of the hypothalamo-pancreatic axis;
however, further research will be necessary to verify this.
Our second aim was to replicate the findings of extra-
hypothalamic CBF change during the hyperglycemic challenge
and attempt to explain its physiology. We observed a
temporal relationship between the hypothalamic and the
extra-hypothalamic CBF changes. Extra-hypothalamic increase
in CBF during glycemic challenge was previously reported
by several studies but its physiological meaning was unclear
(Page et al., 2009). The CBF change in hypothalamus and extra-
hypothalamic regions followed a two-stage relationship. The
first stage corresponded to the peak concentrations of insulin
and C-peptide. During this stage, which took place during the
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FIGURE 5 | The average time-trends for the blood glucose concentrations (top) and four cerebral regions of interest following glucose uptake.
first 4 min after glucose infusion, the extra-hypothalamic CBF
was inversely correlated with hypothalamic CBF (r2 = −0.68,
p < 0.001). The rise in the hypothalamic CBF corresponded to
a decline in CBF elsewhere. The second stage occurred during
the decline of blood glucose and plasma insulin levels. This
is demonstrated by the continued, near-the-peak values of C-
peptide and significant drop (by 20–30%) in insulin and glucose
levels, presumably due to their clearance from the circulation by
the liver and muscle tissues. Both Factor 1 and 2 rose and Factor
1 remained elevated (by about 8%) for over 10 min and the two
factors were significantly and positively correlated during this
time (r2 = 0.81, p < 0.001).
A combination of two mechanisms, the synthesis of brain’s
glycogen (Paulson et al., 2010) and the activity of the cerebral
networks active at rest (Smith et al., 2009) can potentially explain
the physiology and the spatial pattern of extra-hypothalamic
CBF increases. Brain’s glycogen is stored in astroglial cells and
its concentrations (3–6 µmol/g) represent a significant glucose
reservoir relative to free blood glucose (Oz et al., 2009). The
metabolism of brain’s glycogen is modulated by the ambient
concentrations of glucose and insulin (Brown and Ransom,
2007). It is used as an energy substrate to meet immediate
neuronal energy during activations (DiNuzzo et al., 2011)
and when glucose supply from the blood is inadequate. Two
recent studies demonstrated that brain’s glycogen concentrations
change with alteration in glycemic state. First one is a
study by Choi and colleagues in rats. They demonstrated
that during the transition from hypoglycemia to euglycemia
brain’s glycogen concentration rose until exceeding (by three-
to five-fold) the pre-hypoglycemia level (Choi et al., 2003).
The second one is a study by Oz and colleagues in humans,
where they demonstrated that brain’s glycogen concentrations
declined from euglycemic baseline during modest hypoglycemia
and that glycogen concentrations increased to the point of
“supercompensation” upon restoration of glycemia (Oz et al.,
2009). These data suggest that increase in the extra-hypothalamic
blood flow is associated with synthesis of brain glycogen.
Glycogen synthesis occurs in astrocytes and is associated with
release of vasoactive substances (Shulman et al., 2001; Dunn and
Nelson, 2010). This was shown to cause relaxation of endothelial
cells of parenchymal arterioles and increase in the regional CBF
(Shulman et al., 2001; Dunn and Nelson, 2010).
The regional pattern of the extra-hypothalamic CBF increase
can potentially be explained by activity of the cerebral
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FIGURE 6 | Factor analysis was used to distill the trends the first 20min for the four regions into two orthogonal components (Factor 1 and 2). Factors
1 and 2 showed a significant negative correlation (r = −0.72, p < 0.001) during the first 4min post glucose infusion and a significant positive correlation (r = 0.80, p <
0.001) for the remaining 16min.
networks that are active during rest. The spatial patterns of
three independent resting (default motor-and-sensory and the
executive control) networks were significantly correlated and
explained 26, 8, and 6% of the spatial variance in the glucose-
CBF correlation patterns, respectively. Spontaneous fluctuations
in resting brain give rise to low frequency (<0.1 Hz) coherent
and structured functional networks (Fox and Raichle, 2007). The
regional pattern of the increase in CBF during hyperglycemic
challenge showed the largest spatial overlap with the default
mode network. The default-mode characterizes basal neural
activity and non-directed cognitive processing and diminishes
during goal-directed activity (Fox and Raichle, 2007). This
network is intrinsic to the primate brain and is readily observed
in sleeping infants (Fransson et al., 2007) and in anesthetized
NHPs (Vincent et al., 2007). The high spatial correlation between
the SPM of CBF increases and the default mode network was
driven by the overlap in the spatial patterns that included partial
lobe, thalamus, and the prefrontal and cingulate cortices. The
mesencephalon and thalamus are also frequently observed in
the same independent network components (Biswal et al., 2010).
Two other networks that showed significant spatial overlap,
specifically in the frontal and parietal areas, included the motor-
and-sensory and the executive networks. Our data suggest that
the extra-hypothalamic CBF could be associated with uptake
of glucose and increases in brain’s glycogen supply, specifically
in the nodes of the brain networks that are active in the
anesthetized state. This is consistent with previous findings,
in which cerebral glucose metabolism was demonstrated to be
highly associated with brain activity at varying doses of anesthesia
(Shulman et al., 2009). The significant spatial overlaps between
glucose metabolism-induced CBF increases and the default mode
network may thus serve as an index for brain energy-activity
interaction during hyperglycemia. However, the highest spatial
correlation, with the default mode network, explained only 26%
of the variance and therefore the role of cerebral networks
in explaining the spatial pattern of extra-hypothalamic CBF
changes that are active during rest remains putative. Additionally,
the potential role of glycogen as a transferable metabolic
intermediates has been questioned based on its high-energetic
cost, suggesting that the energetic dependence of neurons on
astrocytic glycogen is modest (DiNuzzo et al., 2011). Further
investigation that includes spectroscopic and/or FDG-PET based
assessments of brain’s glucose metabolism rate and glycogen
concentrations are necessary to get a better understanding of this
physiological mechanism.
LIMITATIONS
Anesthetic drugs such as s-ketamine and isoflurane are known
to act as vasodilators and can increase CBF independently of
the glucose and oxygen metabolism levels (Långsjö et al., 2005).
Ketamine sedation was shown to reduce glucose clearance,
insulin secretion and counter regulatory hormonal production
in a NHP model (Lehmann et al., 1997) and 2% isoflurane
altered glucose uptake in the brain in a rodent model (Nasrallah
et al., 2013). While, in our previous investigation of the effects
of ketamine anesthesia on CBF in healthy baboons, we observed
only minor regional CBF changes in response to different levels
of ketamine anesthesia (dose ranging from 4.8 to 14.6 mg/kg;
Szabó et al., 2008), the effects of anesthetics on the CBF response
to glucose infusion cannot be ruled out. However, the use
of anesthesia (including isoflurane) in whole body metabolic
studies using several NHPmodels, including baboons, is accepted
practice and produces robust clinically translational data (Bodkin
et al., 1989; Chavez et al., 2008; Wang et al., 2013; Tozzo
et al., 2015), although some studies have described alterations
under certain conditions in some animal species (Laber-Laird
et al., 1992). Nevertheless, it is unlikely that the necessity
of ketamine/isoflurane use in baboons precludes its utility in
Frontiers in Neuroscience | www.frontiersin.org 9 February 2017 | Volume 11 | Article 49
Kochunov et al. Cerebral Blood Flow during Hyperglycemic Challenge
whole body metabolic disease studies in controlled experimental
settings.
Another potential limitation of this study is the difference in
animal handling protocols between the hypoglycemic challenges
and the resting-state experiments. Vecuronium bromide was
used in the resting-state experiment to simplify the placement
of the tracheal tube. Vecuronium bromide can suppress the
central respiratory activity and this can potentially alter the
spatial patterns of resting state cerebral networks. We believe
this is a minor limitation because vecuronium bromide was not
used beyond initial dose and because animals were mechanically
ventilated at the same rate in both experiments.
In addition, further research is needed to clarify whether the
CBF changes are reduced if euglycemic or mild hyperglycemic
baseline is used during the hyperglycemic challenge. FDG-
PET studies report that the regional cerebral uptake values
are inversely correlated with the baseline plasma glucose
concentrations (Kawasaki et al., 2008) and this suggests that
a similar trend could be observed for the regional CBF
changes. This analysis did not account for partial volume effects.
However, the high-resolution pCASL imaging (2 × 2 × 3
mm) protocol produced no apparent partial volume artifact in
functional experiments in NHP. The phase errors introduced
by imperfect labeling pulses could be potential confounders
affecting the absolute CBF quantification. Although, our study
aims to compare percent CBF differences before and after
glucose administration, future studies implementing a multi-
phase pCASL (Jung et al., 2010) technique could further improve
the accuracy of the results.
CONCLUSIONS
Our results support the use of the baboon as a pertinent
nonhuman primatemodel and neuroimaging techniques to study
changes in cerebral physiology during metabolic challenges.
Our study in baboons complemented previously reported
findings with time-resolved measurements of cerebral perfusion
associated with changing blood glucose and plasma insulin levels.
We observed that changes in the hypothalamic CBF occurred
concomitantly with the regulatory response to a systemic glucose
change and can potentially be explained by the activation of
the hypothalamo-pancreatic axis. The physiology and the spatial
pattern of extra-hypothalamic CBF can putatively be explained
by the glycogen shunt and the activity of the default mode
network. Further investigations that include assessments of
brain’s glucose metabolism rate and glycogen concentrations are
necessary to get a better understanding of the putative role of
these physiological mechanisms.
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